Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genome-wide scanning for linkage in Finnish breast cancer families.
Huusko P, Juo SH, Gillanders E, Sarantaus L, Kainu T, Vahteristo P, Allinen M, Jones M, Rapakko K, Eerola H, Markey C, Vehmanen P, Gildea D, Freas-Lutz D, Blomqvist C, Leisti J, Blanco G, Puistola U, Trent J, Bailey-Wilson J, Winqvist R, Nevanlinna H, Kallioniemi OP. Huusko P, et al. Among authors: markey c. Eur J Hum Genet. 2004 Feb;12(2):98-104. doi: 10.1038/sj.ejhg.5201091. Eur J Hum Genet. 2004. PMID: 14560309
Genome-wide scan for linkage in finnish hereditary prostate cancer (HPC) families identifies novel susceptibility loci at 11q14 and 3p25-26.
Schleutker J, Baffoe-Bonnie AB, Gillanders E, Kainu T, Jones MP, Freas-Lutz D, Markey C, Gildea D, Riedesel E, Albertus J, Gibbs KD Jr, Matikainen M, Koivisto PA, Tammela T, Bailey-Wilson JE, Trent JM, Kallioniemi OP. Schleutker J, et al. Among authors: markey c. Prostate. 2003 Dec 1;57(4):280-9. doi: 10.1002/pros.10302. Prostate. 2003. PMID: 14601024
Hereditary prostate cancer in Finland: fine-mapping validates 3p26 as a major predisposition locus.
Rökman A, Baffoe-Bonnie AB, Gillanders E, Fredriksson H, Autio V, Ikonen T, Gibbs KD Jr, Jones M, Gildea D, Freas-Lutz D, Markey C, Matikainen MP, Koivisto PA, Tammela TL, Kallioniemi OP, Trent J, Bailey-Wilson JE, Schleutker J. Rökman A, et al. Among authors: markey c. Hum Genet. 2005 Jan;116(1-2):43-50. doi: 10.1007/s00439-004-1214-7. Epub 2004 Nov 11. Hum Genet. 2005. PMID: 15549392
Localization of a novel melanoma susceptibility locus to 1p22.
Gillanders E, Juo SH, Holland EA, Jones M, Nancarrow D, Freas-Lutz D, Sood R, Park N, Faruque M, Markey C, Kefford RF, Palmer J, Bergman W, Bishop DT, Tucker MA, Bressac-de Paillerets B, Hansson J, Stark M, Gruis N, Bishop JN, Goldstein AM, Bailey-Wilson JE, Mann GJ, Hayward N, Trent J; Lund Melanoma Study Group; Melanoma Genetics Consortium. Gillanders E, et al. Among authors: markey c. Am J Hum Genet. 2003 Aug;73(2):301-13. doi: 10.1086/377140. Epub 2003 Jul 3. Am J Hum Genet. 2003. PMID: 12844286 Free PMC article.
Genome-wide scan for prostate cancer susceptibility genes using families from the University of Michigan prostate cancer genetics project finds evidence for linkage on chromosome 17 near BRCA1.
Lange EM, Gillanders EM, Davis CC, Brown WM, Campbell JK, Jones M, Gildea D, Riedesel E, Albertus J, Freas-Lutz D, Markey C, Giri V, Dimmer JB, Montie JE, Trent JM, Cooney KA. Lange EM, et al. Among authors: markey c. Prostate. 2003 Dec 1;57(4):326-34. doi: 10.1002/pros.10307. Prostate. 2003. PMID: 14601029
Understanding the long-term impact of the COVID-19 pandemic on non-muscle-invasive bladder cancer outcomes: 12-Month follow-up data from the international, prospective COVIDSurg Cancer study.
Alexander CE, Nathan A, Light A, Gao C, Chan V, Khadhouri S, Gallagher K, Byrnes KG, Walters M, Hughes T, Perry R, Okoth K, Magill L, Pinkney T, John JB, McGrath JS, Colquhoun A, Zhang Y, Blackmur J, Etchill E, Tang S, García Escudero D, Stewart G, Kasivisvanathan V; COVIDSurg Collaborative. Alexander CE, et al. BJUI Compass. 2024 Oct 15;5(11):1044-1051. doi: 10.1002/bco2.432. eCollection 2024 Nov. BJUI Compass. 2024. PMID: 39539562 Free PMC article.
143 results